News and Insights

Get the latest CathWorks news, press releases, industry insights, and useful information for physicians, patients, and media.

Insights

TCT 2023 Highlights: CathWorks Leaves its Mark

October 29, 2023

The CathWorks FFRangio® System generated a lot of interest and excitement from interventional cardiologists at the annual TCT conference in San Francisco.…

Insights

CathWorks FFRangio® System: Optimizing Clinical Decision Making Beyond the Numbers
(TCT 2023, San Francisco)

October 29, 2023

CathWorks Hosts SymposiumChaired by Dr. Martin B. Leon At TCT 2023, a world-renowned panel including Dr. Martin B. Leon (Chair), Dr. William Fearon, Dr. Allen Jeremias and Dr. Ajay J. Kirtane shared their experience with the CathWorks…

Press Releases

CathWorks Announces First Patient Enrolled in Global ALL-RISE Study

June 28, 2023

CathWorks announced today that the first patient has been enrolled in the Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment (ALL-RISE)…

Insights

EuroPCR 2023 – FFRangio Takes Center Stage

June 2, 2023

The FFRangio System generated a lot of interest and excitement from interventional cardiologists throughout the four-day EuroPCR conference in Paris. Learn more…

Insights

Integrating FFRangio into your daily practice – Empowering wire-free insights (EuroPCR, Paris 2023)

June 2, 2023

At EuroPCR 2023, panel experts Dr. Martin B. Leon, Dr. Bernard De Bruyne, Dr. Gianluca Campo, Dr. Jonathan Hill, Dr. Ajay Kirtane…

Insights

CathWorks Symposium at CRT 2023

March 30, 2023

Watch the world-renowned panel of physiology experts discuss the benefits of the CathWorks FFRangio System at CRT 2023.

Press Releases

CathWorks Announces Key Events for ACC 2023

March 2, 2023

CathWorks announced today key events for the company during the annual American College of Cardiology (ACC) 2023 conference…

Press Releases

4th generation FFRangio System receives regulatory approval in Japan

Fourth Generation CathWorks FFRangio® System Receives Regulatory Approval in Japan

October 6, 2022

CathWorks announced today the approval of the fourth generation CathWorks FFRangio® System by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The…

Insights

TCT 2022 Was Highly Successful for CathWorks

October 2, 2022

TCT 2022 was highly successful for CathWorks. The CathWorks booth with a prominent and vibrant presence welcomed dozens of physicians who were…

Insights

CathWorks FFRangio® System: A New Era in Coronary Physiology
(TCT Boston 2022)

September 22, 2022

CathWorks and Medtronic hold a symposium, chaired by Dr. Martin B. Leon from Columbia University Irving Medical. At TCT 2022, panel experts…

Press Releases

CathWorks Announces Key Events for TCT 2022

September 15, 2022

CathWorks announced today the schedule of key events for the company during Cardiovascular Research Foundation’s annual Transcatheter Cardiovascular Therapeutics (TCT) 2022 conference…

Press Releases

Medtronic Announces Co-Promotion Agreement With CathWorks, With Path Toward Acquisition

July 12, 2022

Medtronic, a global leader in healthcare technology, today announced it has entered into a strategic partnership agreement with CathWorks. Our partnership with…

News and Insights

TCT 2023 Highlights: CathWorks Leaves its Mark

CathWorks FFRangio® System: Optimizing Clinical Decision Making Beyond the Numbers
(TCT 2023, San Francisco)

CathWorks Announces First Patient Enrolled in Global ALL-RISE Study

EuroPCR 2023 – FFRangio Takes Center Stage

Integrating FFRangio into your daily practice – Empowering wire-free insights (EuroPCR, Paris 2023)

CathWorks Symposium at CRT 2023

CathWorks Announces Key Events for ACC 2023

Fourth Generation CathWorks FFRangio® System Receives Regulatory Approval in Japan

TCT 2022 Was Highly Successful for CathWorks

CathWorks FFRangio® System: A New Era in Coronary Physiology
(TCT Boston 2022)

CathWorks Announces Key Events for TCT 2022

Medtronic Announces Co-Promotion Agreement With CathWorks, With Path Toward Acquisition

Regulatory Status

Contact CathWorks Today